We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Stands Firm on PK Studies for Insulin Biosimilars
EMA Stands Firm on PK Studies for Insulin Biosimilars
May 7, 2015
The European Medicines Agency has rejected calls from industry to use biosimilar reference products from outside the EU unless they are justified using pharmacokinetic tests.